Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

Autologous stem cell transplant (ASCT) is highly effective in selected patients with light chain (AL) amyloidosis. Bortezomib, preceding or following ASCT, improves responses. Satisfactory responses, including at least a partial response, very good partial response (VGPR) with organ response, or com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood Adv
Hauptverfasser: Basset, Marco, Milani, Paolo, Nuvolone, Mario, Benigna, Francesca, Rodigari, Lara, Foli, Andrea, Merlini, Giampaolo, Palladini, Giovanni
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2020
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479942/
https://ncbi.nlm.nih.gov/pubmed/32886751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002219
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge